Curr Eye Res:Ripasudil盐酸盐水合物滴眼对瞳孔动力学的影响

2017-05-02 luowenbo MedSci原创

该研究的目的是为了探讨Ripasudil盐酸盐水合物(GLANATEC(R))滴眼后对瞳孔动力学的影响。14名健康受试者(除屈光不正外无其他眼科疾病)参加了该项研究,他们的平均年龄为30岁。采用单剂量的GLANATEC(R)滴注受试者左眼,测量滴注前与滴注后30分钟、120分钟的瞳孔反应,并同时检测眼内压。

该研究的目的是为了探讨Ripasudil盐酸盐水合物(GLANATEC(R))滴眼后对瞳孔动力学的影响。14名健康受试者(除屈光不正外无其他眼科疾病)参加了该项研究,他们的平均年龄为30岁。采用单剂量的GLANATEC(R)滴注受试者左眼,测量滴注前与滴注后30分钟、120分钟的瞳孔反应,并同时检测眼内压。

结果发现,滴注后30分钟(P<0.05)、120分钟(P<0.01)时,无论右眼眼内压(IOP)是否与基线水平存在显着差异,左眼眼内压(IOP)显着降低并低于基线水平。与此相反,在这三个时间节点左右眼的瞳孔反应并没有表现出明显差异。

因此,低浓度的GLANATEC(R)单次滴眼对瞳孔直径和瞳孔反应可能没有影响。

原文出处:

Satou, Tsukasa,et al. Effects of Ripasudil Hydrochloride Hydrate Instillation on Pupil Dynamics. Curr Eye Res.2017V42N1:54-57

本文系梅斯医学(MedSci)原创编译,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1800261, encodeId=fa3a18002619c, content=<a href='/topic/show?id=f93de22957a' target=_blank style='color:#2F92EE;'>#盐酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72295, encryptionId=f93de22957a, topicName=盐酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Feb 18 07:27:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029820, encodeId=cf922029820ed, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Sun Dec 03 12:27:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793355, encodeId=68701e9335512, content=<a href='/topic/show?id=86eb1549238' target=_blank style='color:#2F92EE;'>#Ripasudil#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15492, encryptionId=86eb1549238, topicName=Ripasudil)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Sat Sep 30 12:27:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393218, encodeId=405e139321828, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu May 04 13:27:00 CST 2017, time=2017-05-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1800261, encodeId=fa3a18002619c, content=<a href='/topic/show?id=f93de22957a' target=_blank style='color:#2F92EE;'>#盐酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72295, encryptionId=f93de22957a, topicName=盐酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Feb 18 07:27:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029820, encodeId=cf922029820ed, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Sun Dec 03 12:27:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793355, encodeId=68701e9335512, content=<a href='/topic/show?id=86eb1549238' target=_blank style='color:#2F92EE;'>#Ripasudil#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15492, encryptionId=86eb1549238, topicName=Ripasudil)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Sat Sep 30 12:27:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393218, encodeId=405e139321828, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu May 04 13:27:00 CST 2017, time=2017-05-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1800261, encodeId=fa3a18002619c, content=<a href='/topic/show?id=f93de22957a' target=_blank style='color:#2F92EE;'>#盐酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72295, encryptionId=f93de22957a, topicName=盐酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Feb 18 07:27:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029820, encodeId=cf922029820ed, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Sun Dec 03 12:27:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793355, encodeId=68701e9335512, content=<a href='/topic/show?id=86eb1549238' target=_blank style='color:#2F92EE;'>#Ripasudil#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15492, encryptionId=86eb1549238, topicName=Ripasudil)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Sat Sep 30 12:27:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393218, encodeId=405e139321828, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu May 04 13:27:00 CST 2017, time=2017-05-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1800261, encodeId=fa3a18002619c, content=<a href='/topic/show?id=f93de22957a' target=_blank style='color:#2F92EE;'>#盐酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72295, encryptionId=f93de22957a, topicName=盐酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sun Feb 18 07:27:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029820, encodeId=cf922029820ed, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Sun Dec 03 12:27:00 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793355, encodeId=68701e9335512, content=<a href='/topic/show?id=86eb1549238' target=_blank style='color:#2F92EE;'>#Ripasudil#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15492, encryptionId=86eb1549238, topicName=Ripasudil)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Sat Sep 30 12:27:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393218, encodeId=405e139321828, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu May 04 13:27:00 CST 2017, time=2017-05-04, status=1, ipAttribution=)]
    2017-05-04 小几洁

相关资讯

PLOS ONE:练瑜伽吗?那要小心这四种瑜伽姿势了

本研究旨在探究人们在做不同的头向下的瑜伽姿势时,其眼内压(IOP)相应的变化。

Graefes Arch Clin Exp Ophthalmol:辅助青光眼引流装置的植入

该研究的目的在于评估难治性青光眼患者在接受辅助青光眼引流装置(GDD)的植入手术后其眼内压控制(IOP)的成功率,另外,研究是否GDD术后可以减少青光眼的药物治疗。

Int Ophthalmol:不使用眼科手术粘连设备进行人工晶状体植入术

本研究目的在于确定在不使用眼科手术粘连设备时能否安全植入单片亲水性丙烯酸酯人工晶状体。该回顾性研究中包括经白内障超声乳化和不使用眼科手术粘连设备的人工晶状体植入术的100眼,使用眼科手术粘连设备进行人工晶状体植入术的80眼作为对照组。